Name the offer
The word “peptide” is only a beginning.
Ask which peptide is proposed for you and what it is meant to do. “Peptide therapy” alone leaves too much unanswered.
Some peptide medicines have approval
The U.S. Food and Drug Administration is called the FDA here. Semaglutide (Ozempic, Wegovy) has FDA approval, as checked September 26, 2026. That does not settle the question for a different peptide, product or use.
Compounding is a different route
Compounding means a pharmacist or doctor makes medicine to fit a patient's needs, rather than handing out a drug company's finished product. Compounding can be legal when rules for the pharmacy, prescription and ingredients are met (checked September 26, 2026).
A pharmacy's compounded medicine has no FDA approval (checked September 26, 2026). With a compounded medicine, there is no FDA check of safety or how well it works before sale (recorded September 26, 2026). It also does not check how well the medicine was made before sale.
Ask why a compounded product is being proposed for you and what rules allow that exact preparation.
Separate the forms
GHK-Cu on skin is its own question.
GHK-Cu pairs a small peptide with copper. Start by asking which form is offered: something to put on skin, or an injection. Keep that answer beside the product name.
Appearance claims need a closer look
No GHK-Cu medicine had FDA approval in any form when checked September 30, 2026. A GHK-Cu cream sold only for appearance is a cosmetic and needs no FDA approval before sale, under rules checked September 30, 2026.
A product promised to change how skin is built or how it works comes under drug rules (checked September 30, 2026). An example is a cream said to make skin produce more collagen, the protein that gives skin strength. Ask what the product claims to do, rather than relying on the word “cosmetic.”
Look for research in people
Reviews found little research in people for GHK-Cu; most treatment studies involved few people and tested face creams (checked September 30, 2026). Ask to see the research behind the exact claim. Was the same product used in the same way? What changed for the people in the study?
A clear answer can include uncertainty. It need not become a sales pitch.
Keep the route in view
An injection needs its own answer.
“Withdrawn” means the requests were taken back
On its compounding page marked current April 22, 2026, the FDA labels injected GHK-Cu “nominated but withdrawn”. Groups had asked the FDA to allow GHK-Cu for injections in compounded medicines, then took those requests back. Taking back a request gave no approval or clearance for injections (checked September 30, 2026). That entry gives a pharmacy no permission to prepare GHK-Cu injections. Ask whoever offers the shot what rules allow that exact product.
The concern is about injected products
The FDA warns that the body's defense system may react against injected GHK-Cu (recorded September 30, 2026). This unwanted reaction may happen if the peptide clumps together or contains unwanted substances. The same warning says there is too little information from people given it to judge safety well.
ClinicalTrials.gov, the U.S. study register, had no study testing GHK-Cu injections in people in a search on September 30, 2026. That search result does not cover every study worldwide. Ask for evidence about injections when an injection is the offer.
Other forms have a separate listing
For GHK-Cu used without injections, the FDA has a temporary policy for pharmacies (checked September 30, 2026). If a pharmacy meets that policy's conditions, the FDA says it will usually hold off stopping or penalizing it for using the ingredient. The ingredient remains under review. This policy gives no FDA approval and does not establish that a particular product is lawful. Ask the pharmacy which conditions apply to your product and how it meets each one. The listing alone cannot answer that for your order.
Keep the form and the claim together. A cream is not evidence for an injection.
Put names to the care
Check the person, then the pharmacy.
Use the Texas license records
For a clinic visit or care over video, ask who will examine you. Ask separately who would write a prescription. Care carried out at a distance is called telehealth. A nurse practitioner is a nurse with further training in checking health and providing care. A physician assistant also has training in checking health and providing care, but is not a doctor.
The Texas Medical Board has a name search for doctors and physician assistants (checked September 26, 2026). Their records can include board orders, formal decisions that can include discipline for breaking professional rules. The Texas Board of Nursing keeps nurse license records, including those for nurse practitioners (checked September 26, 2026).
The Texas State Board of Pharmacy keeps the pharmacy license records, as checked September 26, 2026. Ask for both names: the person caring for you and the pharmacy making the medicine. The license search links are together in the further reading below.
Ask how prescribing is supervised
To write prescriptions in Texas, a nurse practitioner or physician assistant needs a doctor's supervision and a written prescribing agreement (checked September 26, 2026). That agreement is signed by the doctor and the nurse practitioner or physician assistant, rather than by you. Ask who that doctor is and how questions about your care reach them.
A screen does not lower the standard
Texas requires the same standard of care for a telehealth visit as for the same care in person (rules checked September 26, 2026). Before telehealth care begins, the person caring for you must make sure you understand the proposed care and agree to it (rule checked September 26, 2026). This is called informed consent. Have them explain what happens during the visit and how to bring up your own questions.
In a visit, put your main concern into your own words. Ask what choices are worth discussing, including doing nothing for now. Ask for unfamiliar words to be said another way.
Bring the names of medicines and skin products you use, along with your health questions. Ask whether an examination or tests are needed and who would arrange them. Then ask who handles follow-up if something worries you.
An offer without a prescription is a red flag
Giving out a medicine that requires a prescription without a valid one breaks federal law (checked September 26, 2026). If the person prescribing, the product or the pharmacy cannot be named, leave the decision open until those questions have answers.
If other treatments come up, ask for a separate explanation and the name of the person responsible. That includes fillers (injections that add fullness under the skin), lasers (focused beams of light) and IV drips (fluids given through a vein).
Get the whole bill
An opening price is only a question.
Ask for a written total
No government medicine program published a price for GHK-Cu in the September 30, 2026 check. There was also no drug company with an approved GHK-Cu medicine to publish a price. There is no official price here to use as an estimate for your bill. Ask for a quote tied to the exact product and the care being proposed.
Have the quote show what the visit itself costs. Ask where medicine, tests and delivery sit in that total, and whether follow-up adds a fee. Ask what you pay if no treatment is prescribed. If a package is offered, ask what is included and what costs extra.
Read past the opening offer
For comparison, the online weight-loss plans checked September 26, 2026 charged for medicine on top of their monthly fees. Those offers do not tell us the price of a Houston visit or GHK-Cu. Use them as a question to ask about any monthly fee: does it include your medicine?
What is charged now, what repeats, and what changes after an opening offer? Ask about cancellation dates, unused treatment and refunds. Keep a written copy of those terms for comparison with later charges.
Keep coverage as a separate question
For insurance questions, tell the plan the product's name and the purpose of treatment. Ask the clinic for any details the plan requests. Wait for a coverage answer before counting on that money.
A page to take with you
Keep the questions that matter to you.
Mark the questions you want to carry into a visit. Keep the ones that fit your conversation.
Your marks last until this page is reloaded.
If copying is unavailable, select this text and copy it from here.
The reading behind the answers
Go a little further, if you want.
Open the license tool that matches the person or pharmacy you are checking. The product rules and research reviews are here too, for a closer read.